Europe — EMA

Oxaliplatin Pliva

Oxaliplatin, the active ingredient in Oxaliplatin Pliva, is a platinum‑based chemotherapy presented as a sterile solution for intravenous infusion use.

Oxaliplatin

Request sourcing

Pack/s

What is Oxaliplatin?

Oxaliplatin, the active ingredient in Oxaliplatin Pliva, is a platinum‑based chemotherapy presented as a sterile solution for intravenous infusion use. It is employed in the treatment of certain solid tumours, particularly colorectal cancer, in adult patients. GNH USA supplies Oxaliplatin Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

GNH USA supplies Oxaliplatin Pliva as a licensed, GDP‑compliant international pharmaceutical supplier serving oncology centres, hospitals and pharmacies worldwide.

What is Oxaliplatin used for?

Oxaliplatin Pliva is a platinum‑based chemotherapeutic agent used in the management of malignancies that involve the colorectal pathway.

- Colorectal cancer: Improves survival and reduces tumour growth in adjuvant and metastatic settings. - Gastric cancer: Used in combination regimens to enhance treatment response of the disease by the the the the g t t. - Advanced g \

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Send a sourcing enquiry for this product →